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ABSTRACT 
Hepatitis C virus (HCV) infected 30,500 people in the United States alone in 2014. As a 
positive-sense single-stranded RNA virus, the HCV genome facilitates translation and replication 
of the virus within the host cell. During infection, HCV subverts numerous host proteins to aid in 
viral production. One such protein is DDX6, a DEAD-box helicase that is associated with the 
decapping complex and microRNA Induced Silencing Complex (miRISC).  Previous studies in 
our lab have shown that DDX6 is required for HCV expression. Specifically, DDX6 modulates 
the interaction of miR-122 with the HCV 5’ UTR and promotes stability and replication of the 
viral genome.  To elucidate which enzymatic activities of DDX6 are required to promote HCV 
gene expression, we used site-directed mutagenesis to disrupt the enzymatic activities of DDX6. 
Specifically, we mutated the ATPase, RNA binding and helicase domains within 3x-Flag-
DDX6Δsi plasmid DNA. We next used lentivirus transduction to stably express the 3xFlag-
tagged DDX6 mutants in Huh7 cells, in which expression of endogenous DDX6 was deleted by 
gene editing using CRISPR-Cas9. Analysis by immunofluorescence staining and confocal 
microscopy of uninfected cells, shows wild-type 3xFlag-DDX6 localizing in processing bodies, 
while the enzymatic mutants show diffuse cytoplasmic staining. DDX6 stable cell lines were 
infected with the HCV infectious clone JFH-1, and at three-days post-infection cells were 
harvested and viral and cellular protein and RNA abundance analyzed by western and northern 
blotting, respectively.  Surprisingly, only DDX6 knock-out cells expressing the wild-type 
3xFlag-DDX6 were infected with HCV. These data show that the enzymatic activities of DDX6 
are critical for HCV infection.  Since RNA helicases unwind RNA, it is possible that the helicase 
and RNA binding activities of RCK/p54 are necessary to remodel the complex secondary 
structures found on the 5’ and 3’ untranslated regions of the HCV genome, and may play an 
important role in the transition between translation and replication. 
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INTRODUCTION 
Hepatitis C virus (HCV) infects 71 million people globally. The virus is primarily spread 
through contaminated blood. Approximately 25% of individuals will develop an acute infection. 
Most patients however develop a chronic infection, and this chronic infection increases the 
patient’s risk to develop serious liver problems such as cirrhosis of the liver and hepatocellular 
carcinoma.1 The early HCV treatments used the dual treatment strategy with interferon- and 
ribavirin. While effective, the interferon-/ribavirin treatment had limited success, as patients 
frequently became nonresponsive and developed severe side effects.2 More recently direct-acting 
antivirals (DAAs), targeting the HCV NS3/4A protease, NS5A phosphoprotein and NS5B RNA-
dependent RNA polymerase, have become available.2 Although these DAAs have significantly 
improved treatment outcomes, the NS3/4A inhibitors in particular, show lower reactivity across 
the HCV genotypes and resistance variants are common. 2 Therefore continuing research on 
HCV may reveal additional effective anti-HCV therapies.   
 
Molecular Biology of HCV 
HCV is an enveloped, single-stranded, positive-sense RNA virus in the Flaviviridae 
family of viruses.3 Other well known viruses in this family include Yellow Fever virus, West 
Nile virus, Dengue virus and the recently re-emerging Zika virus. The viral RNA contains a 
single open reading frame, and 5’ and 3’ untranslated regions (UTRs) (Figure 1). HCV uses the 
viral genome as a template for translation and replication within the host cell. Translation of the 
HCV genome is directed by the binding of a 40S ribosomal subunit directly to the internal 
ribosomal entry site in the 5’ untranslated region which results in the production a polyprotein 
that is cleaved into ten viral proteins. The three structural proteins (core, envelope E1 and E2) 
 
Figure 1. Schematic of the HCV genome. The red box highlights the internal ribosomal entry site. 
5’ UTR 3’ UTROpen Reading Frame (ORF)
7 
and seven non-structural (p7, NS2-5B) (Figure 1), and facilitate viral RNA replication and 
assembly into viral particles, and suppression of the innate immune response.3 
 The life cycle of HCV occurs entirely in the cytoplasm of the cell.4 The virus binds four 
different receptor and enters the cell by fusing the viral envelope with the cellular endosomal 
membrane. Viral proteins are immediately following release of the viral RNA into the 
cytoplasm. The synthesis of the viral proteins such as the HCV NS3/4A protease, NS5A 
phosphoprotein and NS5B RNA-dependent RNA polymerase facilitate replication of the HCV 
genome. Replication of the HCV genome occurs using a negative-sense RNA intermediate. The 
virus assembles on lipid droplets and buds into the ER. New viral particles are released from the 
cell via the secretory pathway.4 At each step in the life cycle, HCV interacts with numerous host 
cell proteins. My research investigate the role of one such host protein namely RCK/p54. 
 
RCK/p54 (DDX6) 
RCK/54 is a DEAD-box RNA helicase. The protein contains conserved sequences 
associated with ATP binding and hydrolysis, helicase and RNA binding activity.5 The protein is 
a key component of processing bodies, RNA-protein granules associated with mRNA storage 
and degradation. RCK however also functions with other proteins to promote decapping of 
mRNAs and microRNA-mediated gene regulation.5 Interestingly, RCK/p54 has also been shown 
to be an oncogene,6 and is overexpressed in individuals living with chronic HCV infection.7 
Many viruses use RCK, although the function of RCK during infection is largely unknown.5 
Research from the Pager laboratory has previously shown that knockdown of RCK using target-
specific siRNAs decreases the levels of HCV protein and RNA.8 Interestingly this protein also 
co-localized with core protein at lipid droplets suggesting a role in the assembly of new HCV 
particles.8 More recently they have shown that RCK affects the stability and replication of the 
HCV RNA, likely by directly the binding of the liver-specific microRNA miR-122 to a particular 
site in the 5’ UTR.9 We hypothesize that the enzymatic activities of RCK are required to promote 
HCV gene expression. Therefore, the rationale of this project was to express mutant RCK 
proteins containing enzymatic deficiencies in Huh 7 cells and investigate which enzymatic 
properties are important for the HCV life cycle. If any of the enzymatic activities are important 
for HCV gene expression, we predict a decrease in the levels of viral core protein and viral RNA 
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when analyzed by western blot and northern Blot analysis respectively, and a decrease in 
luciferase units for analysis of viral translation and replication using a reporter genome.  
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MATERIALS AND METHODS 
Site-Directed Mutagenesis 
Site-directed mutagenesis on the p3xFlag-RCKΔsi plasmid was performed using a Quick 
Change Lightening Kit (Agilent) and mutagenesis primer with point mutations, as per the 
manufacturer’s instructions. In brief, the following PCR reaction conditions were used: 1 cycle at 
95°C for 2 minutes; 18 cycles at 95°C for 20 seconds, 60°C for 10 seconds and 68°C for 2 
minute; and 1 cycle at 68°C for 5 minutes. Table 1 shows the point-mutations introduced into 
p3xFlag-RCKΔsi. Following the PCR reaction, the DNA wasincubated with 2 µl of Dpn1 and 
transformed into XL10 gold E. coli with 1 µl of -mercaptoethanol for 30 minutes on ice. The 
bacteria was heat shocked at 42°C for 30 seconds and then incubated on ice for 2 minutes. SOC 
media was added after the transformation reaction, and the reaction was shaken at 37°C for one 
hour. The bacteria hereafter were spread onto an agar plate containing LB agar and carbenicillin 
(Sigma) and incubated overnight at 37°C. Two bacterial colonies were picked and grown at 225 
rpm in a 5ml LB solution containing 0.1 mg/ml ampicillin (Sigma) overnight at 37°C. A 
miniprep was performed using EZNA plasmid DNA mini kit (OMEGA Bio-Tech). The plasmids 
were submitted for sequenceanalysis to confirm presence of the mutations. The confirmed 
plasmids were re-transformed into DH5 bacteria, grown overnight on LB agar and carbenicillin 
plates at 37°C. Single-colonies were picked to start 100ml LB/ampicillin solution. The bacteria 
were grown overnight at 37°C at 225rpm. Hereafter, the plasmid was isolated using an EZNA 
plasmid DNA maxi kit (OMEGA Bio-Tech). 
 
Huh7 and RCK/p54 Huh7 Knockout (KO) Cells 
Huh7 cells are a human hepatoma cell line. In our studies we also used RCK/p54 
knockout Huh7 cells.10 These were generated through CRISPR/Cas9 gene editing and were a 
kind gift from Dr. Jan Carette (Department of Microbiology and Immunology, Stanford 
University). The cells were maintained at 37°C with 5% CO2 in DMEM (Life Technologies), 1 
mM non-essential amino acids (Life Technologies), 10% fetal bovine serum (FBS; Seradigm) 
and 1% L-glutamine (Life Technologies). To passage cells, the media was removed and cells 
were washed two times in 3ml phosphate buffered saline (PS; Life Technologies). Hereafter the 
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cells were incubated in 1ml trypsin/EDTA solution (Life Technologies) for 5 minutes at 37°C. 
The trypsin/EDTA solution was inactivated with normal media and cells replated into 100 mm 
tissue culture plates at 1:3-1:5 ratio. For siRNA and plasmid transfection experiments, Huh7 
cells were seeded into 60 mm tissue culture plates at 8x105 cells per plate 4 hours prior to 
transfection. 
 
Plasmids and siRNAs 
The control plasmid used in this study were the p3xFlag-Bacterial Alkaline Phosphate 
(BAP) (Sigma) and p3xFlag-RCKΔsi wild type (WT). Reference 9 describes the cloning of RCK 
WT into the p3xFlag plasmid, as well as the site-directed mutagenesis PCR perform to mutate 
the RCK siRNA binding site (Δsi), such that expression of 3xFlag-RCKΔsi would not be 
affected by the siRNA gene silencing mechanism.9 The particular mutations to the RCK 
enzymatic activities are as follows: 1) a mutation within the DEAD-box motif (E247Q, 
DEAD>DQAD) to affect ATPase activity; and 2) two different mutations in motif III 
(S277A/T279A, SAT>AAA) and motif Va (G397A; RGID>RAID) to affect helicase activity. 3) 
Two additional mutations were created to affect RNA binding R174A/R225A and 
R174E/R225E. In the first mutant, the arginines are mutated to neutral amino acids (alanine), 
while in the second mutant the arginines are mutated to negatively-charged amino acids 
(glutamic acid). Table 1 shows the point-mutations introduced into p3xFlag-RCKΔsi. The small 
interfering RNAs (siRNAs) used were siGL2 and siRCK/p54: 1) siGL2 (5’- 
CGUACGCGGAAUACUUCGAUU-3’) was used as a negative contro siRNA. This siRNA 
targets Gaussian Luciferase 2 (GL2) mRNA, a gene not expressed in Huh7 cells. siGL2 does not 
affect RCK nor HCV gene expression. 2) siRCK (5’-GCAGAAACCCUAUGAGAUUUU-3’) 
silences endogenous RCK mRNA expression. 
 
Lipofectamine Transfection 
Transfection of Huh7 and RCK KO cells were performed using Lipofectamine 2000 
(Invitrogen). For one transfection reaction, a master mix containing 0.5 ml of OptiMEM was 
added to a 14 ml tube with 10 µl of Lipofectamine 2000. The second master mix containing the 
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siRNA and plasmid was prepared in a separate 14 ml tube. To this tube 500 µl of OptiMEM was 
added together with 5 µl of 20 µM siRNA (final concentration of 100 nM) and 1 g plasmid 
DNA. After a five-minute incubation period, 500 µl of the Lipofectamine 2000 solution was 
added to the tubes containing the siRNA and plasmid. The mixtures were further incubated for 
20 minutes at room temperature. While this mixture was incubating, the media in the Huh7 
plates was aspirated off, and cells were washed with 1 ml of PBS to remove any excess media. 
Then each separate transfection mix was added at 1 ml to each plate. The plates incubated for 4 
hours at 37°C. Hereafter 3 ml of media was added to the cells, and the cells were further 
incubated overnight at 37°C. 
 
HCV Infection of Huh 7 cells 
Twenty-four hours after transfection the Huh 7 cells were infected with the HCV 
infectious clone JFH-1 (a kind gift from Dr. Takaji Wakita, Tokyo Metropolitan Institute of 
Neuroscience) at a multiplicity of infection (MOI) of 0.1. Six hours after infection, the cells were 
trypsinized and re-plated into a 100 mm tissue culture plate. To analyze HCV gene expression, 
cells were harvested 48 hours post-infection (p.i.). Specifically, the media from the infected cells 
was aspirated and the cells were washed in approximately 2 ml of PBS. This wash was then 
aspirated and 1 ml of PBS was added to each plate. The cells were then dislodged using a cell 
lifter. The suspended cells were either divided into two tubes for protein and RNA analysis, 
respectively, or processed further for protein analysis. The cells in PBS were centrifuged for 10 
seconds at 10,000 rpm. The PBS was aspirated and the cell pellet that was re-suspended in 100 
µl of RIPA buffer (100 mM Tris-HCl (pH 7.4), 1% sodium deoxycholic acid, 1% Triton-X100, 
0.1% SDS, 150 mM NaCl, and containing the EDTA-free Complete protease inhibitors cocktail 
(Thermo Fisher Scientific), or 1 ml TRIzol (Life Technologies). Protein lysates were further 
processed by incubation on ice for 20 minutes, and centrifugation at 14,000 rpm at 4°C for 20 
minutes to pellet the cellular debris. The supernatant layer containing the solubilized protein 
lysate was placed in a separate tube to be used for western blot analysis. 
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BCA Quantification 
To measure the concentration of protein in the cell lysates, a 1:5 dilution of the protein 
lysate in PBS. The standard BSA concentrations at 200 ng/µl, 400 ng/µl, 600 ng/µl, 800 ng/µl 
and 900 ng/µl were prepared. A volume of 1.13 µl of reagent A was added to 22.6 µl of reagent 
S to create an “A” solution. First, 25 µl of this solution was added to each well as well as 5 µl of 
each standard and sample. To create a color change, 200 µl of reagent B was then added. The 
absorbance at 562 nm from the BCA protein quantification assay (BioRad) was analyzed using a 
spectrophotometer (BioTek). The standard samples of BSA used to construct a standard curve 
which was then used to calculate the concentrations of protein in the cell lysate. 
 
SDS-Polyacrylamide Gel Electrophoresis (PAGE) and Western Blot Analysis 
Using BCA results, 20 g cell lysate was prepared in RIPA buffer to a final volume of 20 
l, and 5 µl of 5x SDS-PAGE loading buffer. The proteins were then denatured at 95°C for 5 
minutes. The samples (25 µl) were loaded into a 10% SDS-PAGE and electrophoresed at 100 V 
for two hours in 1x SDS-PAGE running buffer. The electrophoresed proteins were transferred 
onto a PVDF membrane (that was activated in methanol) at 100 V for one hour at 4°C. After 
transfer, the membrane was reactivated in methanol, and hydrated in dH2O and 1x PBS. To 
examine consistency of protein loading, the membrane was stained in Ponceau S (Sigma). The 
membrane was then placed in 5% skim “milk” powder in 1x PBS-Tween 20 (PBS-T) for an hour 
at room temperature to block non-specific binding of antibodies to the membrane. The 
membrane was incubated at 4°C overnight in primary antibody in 4 ml of 5% milk in PBS-T. 
The following day, the blot was then washed in PBS-T 3 times for 10 minutes at room 
temperature before incubation in the secondary antibody. The blot was incubated at room 
temperature for one hour in secondary antibody before it was washed again three times with 
PBS-Tween for 10 minutes. The blot was then imaged using a 1:1 mixture of Clarity ECL 
reagent (BioRad) and H2O2. The following primary and secondary antibodies were used: rabbit 
anti-DDX6 (RCK/p54) (1:5,000; Bethyl Laboratories A300-460A), mouse anti-GAPDH 
(Calbiochem); and mouse anti-HCV Core C7-50 (1:1,000; Abcam ab2740), and HRP-conjugated 
donkey anti-mouse and donkey anti-rabbit secondary antibodies (1:10,000; Santa Cruz 
Biotechnologies). 
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Clone 3xFlag Genes into pLenti6/V5-D™-TOPO® Vector 
3xFlag-BAP and RCK/p54 WT and mutant genes in the p3xFlag plasmid were PCR amplified 
using prCTP256 (5’-CACCATGGACTACAAAGACCATGAC-3’) and prCTP169 (5’- 
TTATTAAGGTTTCTCATCTTCTACAGG-3’).  The following PCR reaction was performed 
using the high-fidelity Phusion DNA polymerase (Invitrogen): 1 cycle at 98°C for 30 seconds; 35 
cycles at 98°C for 10 seconds, 55°C for 30 seconds and 72°C for 1 minute 30 seconds; and 1 cycle at 
72°C for 10 minutes. The PCR products were cleaned-up using the QIAquick PCR purification kit 
(QIAGEN) and eluted in 30 l distilled H2O. The PCR product was the incubated with 
pLenti6/V5-D™-TOPO® vector (ThermoFisher) and a salt solution. The cloning reaction was 
incubated at room temperature for 30 minutes. The cloned product (2 µl) was then  added to 50 
µl Stbl3 bacteria (ThermoFisher) and mixed gently. The vial was incubated on ice for 30 minutes 
before heat shocked for 30 seconds at 42°C. After 2 minutes of incubating on ice the cells were 
transferred to a 30 ml tube and 1 ml of SOC was added. The tube was shaken at 37°C for an hour 
before 0.5 ml of the transformation product was plated onto LB agar and carbenicillin and 
incubated at 37°C overnight. As above single colonies were picked for miniprep extraction and 
sequence analysis. The plasmids were re-transformed into Stbl3 bacteria. Colonies were picked 
and shaken with 20 ml LB broth at 37°C overnight. The lentivirus vectors were isolated using a 
midiprep DNA kit (OMEGA Bio-Tech). The following lentivirus plasmids were used: ATPase 
mutation (pLenti3xFlag-RCK-DEAD>DQAD), a Δ prion-related domain (PRD) 
(pLenti3xFLAG-RCK∆PRD), and the helicase mutants (pLenti3xFlag-RCK SAT>AAA and 
pLenti3xFlag-RCK-RGID>RAID). 
 
Production of Lentivirus and Trnsduction of RCK KO Cells 
To produce lentiviruses, 0.75 g pLenti6/V5-BAP and -RCK plasmids were transfected 
into 293FT cells with 2.25 g ViraPower Lentiviral packaging mix using Lipofectamine 3000 
(Invitrogen) according to the manufacturer’s instuctions. Media from transfected cells was 
collected 24 hours post-transfection. This media containing lentivirus was stored at 4°C. Fresh 
media was added to the cells, and again collected at 48 hours post-transfection. Media containing 
lentivirus was filtered through a 0.45 m filter. To create RCK stable Huh7 cells, polybrene 
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(Sigma) was added to the filtered lentivirus, and then added to the RCK KO cells. The RCK KO 
cells were seeded in 60 mm tissue culture plates 24 hours prior transduction. The media 
containing lentivirus and polybrene (6 g/ml; Sigma) were incubated on the KO cells for 24 
hours. Hereafter, the media was removed and replaced with fresh media. The cells were further 
incubated for an additional 24 hours. Forty-eight hours post-transduction, KO cells transduced 
with 3xFlag-BAP and -RCK were trypsinized and re-plated into 100 mm plates. Cells that were 
stably transduced were placed under blasticidin selection (5 µg/µl; Invitrogen). These RCK 
stable Huh7 cells were further maintained in blasticidin. 
 
Northern Blot Analysis  
RNA was extracted with TRIzol (Invitrogen) per the manufacturer’s instruction . Total 
RNA (10 ug) was resuspended in loading buffer (1% MOPS-EDTA-sodium acetate (MESA), 
67% formaldehyde, and 50% formamide). The RNA was denatured at 65°C for 10 minutes and 
then separated in 1% formaldehyde/agarose gels and ran at 100 V. The RNA was transferred 
onto a ZetaProbe membrane (BioRad) overnight and then crosslinked using Stratalinker. The 
membrane was hybridized to examine actin and HCV using ExpressHyb hybridization buffer 
(Clontech) and dATP-RadPrime DNA labeled (Invitrogen) probes [32P].8,9 
 
Luciferase Assay 
The subgenomic HCV reporter plasmids sgJFH-1 RLuc replication-competent (WT) and 
replication-incompetent (GND) were a kind gift from Dr. Glan Randall (University of 
Chicago).11 The plasmids were linearized with XbaI, and the linear DNA used as a template for 
T7 Megascript in vitro transcription (Ambion) according to the manufacturer’s instructions.9 
RCK KO cells stably expressing 3xFlag-BAP, and RCK WT and mutant genes were seeded into 
24 well plates at 5x104 cells/well and incubated overnight at 37°C. Cells were transfected with 
500 ng sgJFH-1 RLuc RNA using Lipofectamine MessengerMAX transfection reagent 
(Invitrogen) according to the manufacturer’s instructions. Cells were lysed in 1x passive lysis 
buffer (Promega) 6 hours and 48 hours post-transfection. Three replicates were measured in 96-
well plates using the Renilla reagent (Promega) in a luminometer (BioTek). This experiment was 
15 
repeated once for replicability. 
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RESULTS 
Knockdown and rescue with wild-type and mutant RCK/p54 protein in Huh7 cells. 
The first step in my study was to created mutations in the ATPase and helicase domains of RCK 
cloned into a 3xFlag-plasmid (Table 1). To investigate the role of the enzymatic activities of 
RCK during HCV 
infection, we 
transfected cells 
with a control 
siRNA(siGL2) and 
a RCK target-
specific siRNA, 
such that endogenous RCK expressed in the cells would be depleted. To investigate the specific 
effects of mutant RCK we co-transfected cells with a control plasmid (p3xFlag-BAP), and 
p3xFlag-RCK WT and mutants. The p3xFLag-RCK plasmid had been further mutated such that 
the mRNA expressed from the plasmid would be resistant to siRNA cleavage. Transfected cells 
were then infected with JFH-1, the HCV infectious clone, and HCV protein abundance examined 
3 days p.i. by western blot analysis. Lane 
1 in Figure 2 shows uninfected Huh7 
cells. As expected no HCV core protein 
was detected, and RCK and GAPDH are 
expressed. Lanes 2-7 show protein from 
HCV-infected cells. Co-transfection of 
siGL2 and p3xFlag-BAP had no effect on 
RCK levels, and HCV core protein is 
visible (lane 2). In contrast, cells 
transfected with siRCK and 3x Flag-BAP 
plasmid resulted in significantly less RCK 
protein and a decrease in HCV core 
protein (lane 3). As expected, the 
depletion of RCK and rescue with 
Enzymatic 
Activity 
Domain aa position WT Motif Mutant 
Motif 
ATPase II E247Q DEAD DQAD 
Helicase III S277A/T279A SAT AAA 
Helicase Va G397A RGID RAID 
RNA Binding Ia-Ic R174A/R225A TRE/GRI TAE/GAI 
RNA Binding Ia-Ic R174E/R225E TRE/GRI TEE/GEI 
 
Table 1. Mutations to disrupt RCK enzymatic activity. 
 
Figure 2. Expression of RCK wild type and 
mutated RCK/p54 proteins during HCV infection. 
Huh7 cells were co-transfected with siRNAs and 
p3xFlag plasmids, and infected with HCV. Protein 
abundance was analyzed by western blot analysis 3 
days p.i. 
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RCKsi WT (lane 4) shows a return to similar viral core level as the siGL2 and BAP plasmid 
transfection in lane 2. Of note, the overexpressed 3xFlag- RCKsi WT and mutant proteins are 
visible using the rabbit anti-RCK antibody. Because of the additional three Flag epitopes at the 
N-terminus of RCK, these proteins migrate slower in the gel and are visible as the band above 
the endogenous RCK band. The rescue with wild type RCK resulted in a double band of RCK. 
Interestingly expression of the mutated RCK proteins deficient in ATPase and helicase activities 
resulted in significantly less HCV core expression (lanes 5-7). The GAPDH levels, used as a 
loading control, were even across all lanes. These data suggest that HCV gene expression 
requires RCK ATPase and helicase activities. 
The initial analysis of RCK enzymatic 
activities included the ATPase and 
helicase motifs, but not the RNA binding 
motif. We therefore created two additional 
mutants in motif Ia and Ic. These motifs 
are predicted to bind RNA and in the RNA 
structure are opporiste from each other. In 
RNA binding motifs, arginine (R) is a 
common amino acids, as the positive 
charge from the amino acid facilitates the 
binding to the negatively-charged 
phosphate backbone of RNA. We 
therefore created two mutations, the first 
mutating the arginines to the neutral amino 
acid alanine (R174A/R225A) and also to 
the negatively-charged glutamic acid (R174E/R225E). We predict both mutations would disrupt 
RNA binding. Figure 3 shows similar results as Figure 2 on HCV core expression for the 
control and RCK mutant proteins. The effect of the two mutant RNA-binding RCK proteins on 
HCV core levels are shown in lanes 8 and 9. Changing the arginine in motifs Ia and Ic to an 
alanine, decreased levels of HCV core protein. Unexpectedly, the point mutation from arginine 
to glutamic acid in lane 9, showed similar HCV core expression as the WT rescue. While motifs 
Ia and Ic are predicted to bind RNA, to our knowledge no biochemical assays have been 
 
Figure 3. Expression of RCK wild type and 
RCK/p54 mutant proteins deficient in ATPase, 
helicase and RNA binding activities during HCV 
infection. Huh7 cells were co-transfected with 
siRNAs and p3xFlag plasmids, and infected with 
HCV. Protein abundance was analyzed by western 
blot analysis 3 days p.i. 
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undertaken to demonstrate this activity. Therefore, the RCK R174A/R225A mutant shows an 
affect on HCV, however additional experiments should be performed before concluding that this 
effect is due to disruption of RNA binding. Performing an immunoprecipitation of RCK WT and 
R174A/R225A and examining RNA binding would be a first step to investigating this. This 
assay would also provide insight into why R174E/R225E had no effect on HCV core expression. 
 
Knockdown and rescue with wild-type and mutant 
RCK/p54 protein in RCK knockout (KO) cells. 
Because of variable knockdown efficiencies using 
siRNAs, these experiments were repeated in Huh7 
cells in which CRISPR-Cas9 gene editing 
technology had been used to knockout RCK.10 In 
Figure 4, lanes 1 and 3 protein lysates from Huh7 
WT cells. In these lanes endogenous RCK is 
detected by western blot analysis. In contrast, but as 
expected, no endogenous RCK is visible in the 
RCK KO cells (Lanes 2 and 4). When HCV 
infection was examined in Huh7 WT and RCK KO 
cells, core protein was only detected in Huh7 WT 
cells (lane 3). These data show that RCK is indeed 
required for HCV gene expression. 
 
We next examined HCV gene expression in RCK KO cells transiently expressing 3xFlag-BAP, 
RCK WT and three enzymatic mutants of RCK (lanes 5-9). While immunoblotting for Flag 
revealed transient expression of the 3xFlag proteins, these proteins were not detected using the 
anti-RCK antibody (Figure 4). Moreover, HCV core protein was not detected (lanes 5-9), not 
even when RCK WT expression was rescued in the RCK KO cells (lane 5). These data indicate 
that transient expression of 3xFlag proteins is unable to rescue HCV gene expression. 
 
 
Figure 4. Transient expression of 3xFlag 
WT and mutant proteins does not rescue 
HCV gene expression. Huh7 cells and 
Huh7 RCK KO were transfected with 
p3xFlag plasmids, and then mock-infected 
or infected with HCV. Protein abundance 
was analyzed by western blot analysis 3 
days p.i. 
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HCV gene expression in RCK KO stably expression 3xFlag BAP and RCK proteins. 
Because transient expression of RCK WT and mutant proteins did not rescue HCV 
gene expression we next sought to stably express these proteins in the RCK KO cells. 
To this end we sub-cloned the 3xFlag-BAP, RCK WT and RCK mutant genes into the 
pLenti vector. Lentiviruses expressing the genes were produced in 293FT cells, and 
subsequently transduced into the RCK KO. Stable gene expression was achieved by 
blasticidin selection.  
Using these stable cells expressing RCK WT and mutant 
proteins we next invested the effect on HCV gene 
expression. Specifically, the cells were infected with HCV 
and cell lysates harvested 3 days p.i. We first investigated 
protein expression by western blot analysis. We detected 
RCK expression in cells stably expressing RCK WT, 
RGID>RAID and SAT>AAA proteins (Figure 5, lanes 1, 
and 4-5). We did not detect RCK expression in cells stably 
expressing a mutant RCK protein in which the prion-
related domain (PRD) had been deleted (lane 3). The anti-
RCK antibody used in our studies targets the N-terminus 
and with the deletion of the PRD domain, the antibody 
recognition site was also deleted. However, the PRD 
RCK protein was detected using the anti-Flag antibody 
(lane 3). Disappointingly, we did not detect HCV protein. 
Because we were unable to detect HCV core protein in Figure 5, we next investigated HCV 
RNA abundance. RNA from the same experiment was extracted and analyzed by northern blot 
(Figure 6). Northern blot analysis confirmed low levels of HCV RNA expression in BAP, 
DDX6-E247Q and DDX6-SAT-AAA stable cell lines. HCV RNA was observed in KO cells 
expressing RCK WT and RCK∆PRD (lanes 1 and 5). Consistent with our earlier data we did not 
detect HCV RNA in cells stably expressing 3xFlag-BAP, or RCK DEAD>DAAD and 
SAT>AAA (lanes 2-4). Figure 5 and Figure 6 together show that HCV can infect RCK KO 
cells stably expressing RCK WT and RCK∆PRD, but not the mutant RCK proteins. Moreover, 
 
Figure 5. HCV gene expression in 
RCK KO cells stably expressing 
3xFlag proteins. Huh7 RCK KO 
stably expressing 3xFlag proteins 
were infected with HCV , and 
protein abundance was analyzed 
by western blot analysis 3 days p.i. 
Note: The data presented in this 
figure are from the same blot. The 
image however was rearranged for 
this figure presentation.  
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the HCV infection in these cells is not as robust as in Huh7 
cells. 
HCV translation and replication in RCK KO stably 
expression 3xFlag BAP and RCK proteins. 
To determine if RCK affects HCV translation or 
replication we used a subgenomic JFH-1 genome assay 
containing the Renilla luciferase.11 This reporter genome 
contains the HCV 5’ UTR followed by the Renilla 
luciferase gene (RLuc). The RLuc is separated from the 
HCV nonstructural proteins by an EMCV IRES. The 3’ 
UTR flanks the ORF containing the HCV NS2-NS5B 
proteins. The sgJFH-1 genome was in vitro transcribed and 
transfected into the RCK KO cells stably expressing 
3xFlag proteins. Because the HCV genome is singl-
stranded positive-sense, the RNA is translated at early time points post-transfection (e.g. 6 
hours). However over time and the accumulation of the HCV nonstructural proteins necessary 
for replication, replication the sgJFH-1 genome, and with the increase in HCV genomes 
luciferase activity at 48 hours post-transfection may be used as a proxy for replication. We 
therefore measured luciferase expression 6 and 48 hours post-transfection (Figure 6), while the 
luciferase measurement 48h post transfection served as a proxy for replication. For the RCK WT 
we observed modest luciferase activity at 6 
hours, which increased at 48 hours. In contrast 
we observed low luciferase activity in cells 
stably expressing the RCK the helicase mutant 
(SAT>AAA).While these data are consistent 
with earlier data we did observed modest 
luciferase activity at 48 hours post-infection, 
suggesting that the helicase activity of RCK 
may be important for HCV translation. For the 
RCK ∆PRD mutant we observed luciferase 
activity similar to RCK WT at 6 hours post-
 
Figure 5. HCV RNA abundance in 
RCK KO cells stably expressing 
3xFlag proteins. Huh7 RCK KO 
stably expressing 3xFlag proteins 
were infected with HCV, and RNA 
abundance was analyzed by 
norther blot analysis 3 days p.i. 
Note: The data presented in this 
figure are from the same blot. The 
image however was rearranged for 
this figure presentation. 
Note: These data are from Gaston 
Bonenfant, and used in this Thesis 
with permission. 
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Figure 6. HCV translation and replication in 
RCK KO cells stably expressing 3xFlag 
proteins. Huh7 RCK KO stably expressing 
3xFlag proteins were transfected with in vitro 
transcribed sgJFH-1 RLuc RNA, and 
harvested and Renilla luminescence measured 
at 6 and 48 hours post-transfection.  
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transfection. However, at 48 hours RCK ∆PRD dramatically increased luciferase data, 
suggesting that PRD may limit HCV. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
DISCUSSION 
The goal of this project was to investigate the role of RCK/p54 enzymatic activities on HCV 
infection. To this end, 3xFlag-tagged RCK/p54 plasmids containing mutations in the enzymatic 
domains (e.g. sites involved in ATPase, helicase, and RNA binding) were expressed in Huh7 
cells depleted of endogenous RCK/p54 and infected with HCV. The results shown in Figure 2 
and Figure 3 demonstrate successful knockdown of endogenous RCK and a corresponding 
decrease in expression of HCV core following expression of the mutant RCK proteins. The 
reduction of HCV core protein following expression of RCK/p54 containing mutations inhibiting 
helicase (SAT>AAA; RGID>RAID), and ATPase (DEAD>DQAD) activities suggest these 
enzymatic activities are critical for the function of RCK/p54 in promoting HCV gene expression.  
 
RCK is a DEAD-box RNA helicases. Other proteins in this family have been shown to unwind 
RNA, or RNA-protein interactions. Because ablation of the ATPase and helicase activities 
affected HCV gene expression it is possible that these activities of RCK/p54 are necessary to 
remodel the complex secondary structures found on the 5’ and 3’ untranslated regions of the 
HCV genome, and/or remodel RNA-proteins to promote the transition between translation and 
replication. 
 
Mutating the putative RNA binding domain (R174/225A) also decreases of HCV core levels. 
Unexpectedly, the R174/225E mutant did not have the same effect on HCV core protein. This 
difference in RNA binding phenotypes may be a consequence of a possible conformation change 
in the RCK protein or alternate mechanism to bind HCV RNA. While motifs Ia and Ic are 
putative RNA binding domains, it is possible that these regions do not bind RNA, and rather 
have a completely different function. 
 
The observed decrease in HCV expression suggests that each of these mutations interfere with 
the HCV infection. We verified these results in Huh7 cells lacking RCK. However, we did not 
observe rescue of HCV gene expression when RCK was transiently expression, likely due to 
inefficient transfection. To address this, we created RCK KO cells that stably express the 3xFlag-
23 
tagged proteins. In cells stably expressing RCK WT and ∆PRD we were able to detect HCV 
RNA but not HCV core protein. However, using a sgJFH-1 RLuc reporter genome we 
determined that the helicase mutant SAT>AAA likely affects translation, while the ∆PRD 
promotes replication. Together this data indicates that HCV might subvert RCK to facilitate viral 
gene expression at different steps in the infectious cycle.  
24 
REFERENCES 
1. Center for Disease Control and Prevention (2016). Viral Hepatitis C-Hepatitis C 
Information. Received from: 
http://www.cdc.gov/hepatitis/hcv/cfaq.htm#cFAQ11 
2. Bartenschlager R, Lohmann V, Penin F. The molecular and structural basis of advanced 
antiviral therapy for hepatitis C virus infection. Nature Reviews Microbiology. 
2013;11(7):482-96.  
3. Lindenbach BD, Rice CM. Flaviviridae:  The Viruses and Their Replication. 6 ed. Knipe 
DM, Howley PM, editors. Philadelphia, Pennsylvania: Lippincott-Williams & Williams 
Publishers; 2013. 712-46 p. 
4. Lindenbach, B.D., and Rice, C.M. (2005). Unravelling Hepatitis C Virus 
Replication from Genome to Function. Nature. Vol 436; 933-938. 
5. Presnyak V, Coller J. The DHH1/RCKp54 family of helicases: an ancient family of proteins 
that promote translational silencing. Biochimica et biophysica acta. 2013;1829(8):817-23. 
6. Akao Y, Marukawa O, Morikawa H, Nakao K, Kamei M, Hachiya T, Tsujimoto Y. The 
rck/p54 candidate proto-oncogene product is a 54-kilodalton D-E-A-D box protein 
differentially expressed in human and mouse tissues. Cancer research. 1995;55(15):3444-9. 
7. Miyaji K, Nakagawa Y, Matsumoto K, Yoshida H, Morikawa H, Hongou Y, Arisaka Y, 
Kojima H, Inoue T, Hirata I, Katsu K, Akao Y. Overexpression of a DEAD box/RNA 
helicase protein, rck/p54, in human hepatocytes from patients with hepatitis C virus-related 
chronic hepatitis and its implication in hepatocellular carcinogenesis. Journal of viral 
hepatitis. 2003;10(4):241-8. 
8. Pager CT, Schutz S, Abraham TM, Luo G, Sarnow P. Modulation of hepatitis C virus RNA 
abundance and virus release by dispersion of processing bodies and enrichment of stress 
granules. Virology. 2013;435(2):472-84. 
9. Biegel JM, Henderson E, Cox EM, Bonenfant G, Netzband R, Kahn S, Eager R, Pager CT. 
Cellular DEAD-box RNA helicase DDX6 modulates interaction of miR-122 with the 5' 
untranslated region of hepatitis C virus RNA. Virology. 2017 Jul;507:231-241. 
25 
10. Lumb JH, Li Q, Popov LM, Ding S, Keith MT, Merrill BD, Greenberg HB, Li JB, Carette 
JE. DDX6 Represses Aberrant Activation of Interferon-Stimulated Genes. Cell Rep. 2017 Jul 
25;20(4):819-831. 
11. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, Jordan TX, Mateu G, Grakoui A, 
Randall G. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in 
hepatitis C virus replication. Proceedings of the National Academy of Sciences of the United 
States of America. 2009;106(18):7577-82. 
 
